CCCC
C4 Therapeutics Inc
Price:
1.48
USD
Volume:
745,256
United States | Biotechnology
CCCC Probability of Bankruptcy
The Probability of Bankruptcy of C4 Therapeutics Inc (CCCC) is 60.7% . This number represents the probability that CCCC will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating CCCC's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
CCCC - Historical Solvency Measures
to of
Page of
CCCC - ESG ratings
ESG ratings are directly linked to the cost of capital and CCCC's ability to raise funding, both of which can significantly affect the probability of C4 Therapeutics Inc going bankrupt.
ESG Score
72.17
Environment Score
77.35
Social Score
79.85
Governance Score
59.3
| Returns | |
| Historical Returns (5 day) | - |
| Historical Returns (MTD) | -8.54% |
| Historical Returns (YTD) | -58.33% |
| Historical Returns (13 week) | -55.49% |
| Historical Returns (26 week) | -76.74% |
| Historical Returns (52 week) | -75.65% |
| Efficiency | |
| Asset Turnover | 0.11 |
| Receiveable Turnover | 3.68 |
| Gross Margin | - |
| Operating Margin | - |
| Pretax Margin | - |
| Net Margin | - |
| Return on Asset (ROA) | -28.96 |
| Return on Equity (ROE) | -45.86 |
| Return on Investments (ROI) | -45.86 |
| Price Metrics | |
| Market Cap (M) | 105.1 |
| Enterprise Value (M) | 53.8 |
| 52 Week High | 7.66 |
| 52 Week Low | 1.09 |
| Beta | 3.01 |
| Average Volume (10 day) | 1.03 |
| Average Volume (3 month) | 1.42 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 2.4 |
| Earnings | |
| EPS | -1.47 |
| Revenue CAGR (5 year) | 10.73% |
| Risk | |
| Current Ratio | 5.7 |
| Quick Ratio | 5.47 |